M. Davanlou

Cancer incidence and mortality in Iran.

Seyed Mohsen Mousavi, M. M. Gouya, S M Mousavi, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

S. Parmar, M. Estecio, H. Kantarjian, 2013, Leukemia.

Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review.

K. Young, L. Medeiros, C. Bueso-Ramos, 2017, Annals of diagnostic pathology.

Cancer in Iran 2008 to 2025: Recent incidence trends and short‐term predictions of the future burden

R. Malekzadeh, J. Ferlay, F. Bray, 2021, International journal of cancer.

Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry.

R. Malekzadeh, H. Poustchi, G. Roshandel, 2019, Cancer epidemiology.

Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.

G. Bhagat, M. Routbort, K. Young, 2016, Human pathology.

Cancer incidence and mortality in Iran.

Seyed Mohsen Mousavi, M. M. Gouya, R. Ramazani, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.